Delafloxacin

Generic name: Pronounced as (del" a flox' a sin)
Brand names
  • Baxdela®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 02/15/2020

Taking delafloxacin increases the risk that you will develop tendinitis (swelling of a fibrous tissue that connects a bone to a muscle) or have a tendon rupture (tearing of a fibrous tissue that connects a bone to a muscle) during your treatment or for up to several months afterward. These problems may affect tendons in your shoulder, your hand, the back of your ankle, or in other parts of your body. Tendinitis or tendon rupture may happen to people of any age, but the risk is highest in people over 60 years of age. Tell your doctor if you have or have ever had a kidney, heart, or lung transplant; kidney disease; a joint or tendon disorder such as rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function); or if you participate in regular physical activity. Tell your doctor and pharmacist if you are taking oral or injectable steroids such as dexamethasone, methylprednisolone (Medrol), or prednisone (Rayos). If you experience any of the following symptoms of tendinitis, stop taking delafloxacin, rest, and call your doctor immediately: pain, swelling, tenderness, stiffness, or difficulty in moving a muscle. If you experience any of the following symptoms of tendon rupture, stop taking delafloxacin and get emergency medical treatment: hearing or feeling a snap or pop in a tendon area, bruising after an injury to a tendon area, or inability to move or bear weight on an affected area.

Taking delafloxacin may cause changes in sensation and nerve damage that may not go away even after you stop taking delafloxacin. This damage may occur soon after you begin taking delafloxacin. Tell your doctor if you have ever had peripheral neuropathy (a type of nerve damage that causes tingling, numbness, and pain in the hands and feet). If you experience any of the following symptoms, stop taking delafloxacin and call your doctor immediately: numbness, tingling, pain, burning, or weakness in the arms or legs; or a change in your ability to feel light touch, vibrations, pain, heat, or cold.

Taking delafloxacin may affect your brain or nervous system and cause serious side effects. This can occur after the first dose of delafloxacin. Tell your doctor if you have or have ever had seizures, epilepsy, cerebral arteriosclerosis (narrowing of blood vessels in or near the brain that can lead to stroke or ministroke), stroke, changed brain structure, or kidney disease. If you experience any of the following symptoms, stop taking delafloxacin and call your doctor immediately: seizures; tremors; dizziness; lightheadedness; headaches that won't go away (with or without blurred vision); difficulty falling asleep or staying asleep; nightmares; not trusting others or feeling that others want to hurt you; hallucinations (seeing things or hearing voices that do not exist) or delusions (strange thoughts or beliefs that have no basis in reality); thoughts or actions towards hurting or killing yourself; feeling restless, anxious, nervous, depressed, or confused; memory problems; or other changes in your mood or behavior.

Taking delafloxacin may worsen muscle weakness in people with myasthenia gravis (a disorder of the nervous system that causes muscle weakness) and cause severe difficulty breathing or death. Tell your doctor if you have myasthenia gravis. Your doctor may tell you not to take delafloxacin. If you have myasthenia gravis and your doctor tells you that you should take delafloxacin, call your doctor immediately if you experience muscle weakness or difficulty breathing during your treatment.

Talk to your doctor about the risks of taking delafloxacin.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with delafloxacin. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.

Delafloxacin is used to treat skin infections and certain types of pneumonia (an infection of the lungs) caused by bacteria in adults. Delafloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the bacteria that cause infections.

Antibiotics such as delafloxacin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Delafloxacin comes as a tablet to take by mouth. It is usually taken with or without food twice a day (every 12 hours). Take delafloxacin at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take delafloxacin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

You should begin to feel better during the first few days of treatment with delafloxacin. If your symptoms do not improve or get worse, call your doctor.

Take delafloxacin until you finish the prescription, even if you feel better. Do not stop taking delafloxacin without talking to your doctor unless you experience certain serious side effects listed in the IMPORTANT WARNING or SIDE EFFECTS sections. If you stop taking delafloxacin too soon or skip doses, your infection may not be completely treated and the bacteria may become resistant to antibiotics.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking delafloxacin,

  • tell your doctor and pharmacist if you are allergic or have had a severe reaction to delafloxacin, any other quinolone or fluoroquinolone antibiotic such as ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), and ofloxacin, any other medications, or any of the ingredients in delafloxacin tablets. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and insulin or other medications to treat diabetes such as chlorpropamide, glimepiride (Amaryl, in Duetact), glipizide (Glucotrol), glyburide (DiaBeta), tolazamide, and tolbutamide. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • if you are taking antacids containing aluminum hydroxide or magnesium hydroxide (Maalox, Mylanta, others), or certain medications such as didanosine (Videx) solution, sucralfate (Carafate), or vitamin or mineral supplements that contain iron or zinc, take these medications 6 hours before or 2 hours after you take delafloxacin.

  • tell your doctor if you have or have ever had an aortic aneurysm (swelling of the large artery that carries blood from the heart to the body), high blood pressure, peripheral vascular disease (poor circulation in the blood vessels), Marfan syndrome (a genetic condition that can affect the heart, eyes, blood vessels and bones), Ehlers-Danlos syndrome (a genetic condition that can affect skin, joints, or blood vessels), diabetes, or problems with low blood sugar.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking delafloxacin, call your doctor.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if you are supposed to take your next dose in 8 hours or less, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Delafloxacin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • vomiting

    • diarrhea

    • headache

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, stop taking delafloxacin and call your doctor immediately or get emergency medical treatment:

    • severe diarrhea (watery or bloody stools) that may occur with or without fever and stomach cramps (may occur up to 2 months or more after your treatment)

    • rash, itching, hives, shortness of breath, tingling or swelling of the face or throat, or fainting

    • extreme thirst or hunger; pale skin; feeling shaky or trembling; fast or fluttering heartbeat; sweating; frequent urination; trembling; blurred vision; or unusual anxiety

    • sudden pain in the chest, stomach, or back

  • Delafloxacin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to delafloxacin. If you have diabetes, your doctor may ask you to check your blood sugar more often while taking delafloxacin.

Do not let anyone else take your medication. Your prescription is probably not refillable. If you still have symptoms of infection after you finish the delafloxacin, call your doctor.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Moxifloxacin.
Repaglinide Repaglinide The therapeutic efficacy of Repaglinide can be increased when used in combination with Delafloxacin.
Montelukast Montelukast The metabolism of Montelukast can be increased when combined with Delafloxacin.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The therapeutic efficacy of Insulin glargine can be increased when used in combination with Delafloxacin.
Leflunomide Leflunomide The metabolism of Leflunomide can be increased when combined with Delafloxacin.
Nevirapine Nevirapine The metabolism of Nevirapine can be increased when combined with Delafloxacin.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Delafloxacin.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Anagrelide.
Calcium Carbonate Calcium Carbonate Calcium carbonate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Candesartan Candesartan The metabolism of Candesartan can be increased when combined with Delafloxacin.
Cilostazol Cilostazol The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Delafloxacin.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be increased when combined with Delafloxacin.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Fenofibrate Fenofibrate Fenofibrate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Guanfacine Guanfacine Guanfacine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Magnesium Gluconate Magnesium Gluconate Magnesium gluconate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide Magnesium Hydroxide Magnesium hydroxide can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide Magnesium Oxide Magnesium oxide can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Miglitol Miglitol The therapeutic efficacy of Miglitol can be increased when used in combination with Delafloxacin.
Mycophenolate Mycophenolate Mycophenolic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Penbutolol Penbutolol The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Acebutolol.
Potassium Potassium Potassium cation may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone The risk or severity of tendinopathy can be increased when Prednisone is combined with Delafloxacin.
Ranitidine Ranitidine Ranitidine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Reserpine Reserpine Reserpine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Rizatriptan Rizatriptan Rizatriptan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Delafloxacin.
Triamcinolone Triamcinolone The risk or severity of tendinopathy can be increased when Triamcinolone is combined with Delafloxacin.
Ampicillin Injection Ampicillin Injection The serum concentration of Delafloxacin can be increased when it is combined with Ampicillin.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Famotidine is combined with Delafloxacin.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Delafloxacin.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Levofloxacin.
Meperidine Injection Meperidine Injection Meperidine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of tendinopathy can be increased when Methylprednisolone is combined with Delafloxacin.
Metoclopramide Injection Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Metoclopramide is combined with Delafloxacin.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Delafloxacin.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Delafloxacin may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The metabolism of Delafloxacin can be increased when combined with Zidovudine.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cyclosporine Cyclosporine The risk or severity of nephrotoxicity can be increased when Delafloxacin is combined with Cyclosporine.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ondansetron.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Granisetron.
Torsemide Torsemide Delafloxacin may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Delafloxacin.
Alosetron Alosetron The metabolism of Alosetron can be increased when combined with Delafloxacin.
Dofetilide Dofetilide The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Dofetilide.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Delafloxacin.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Temozolomide Temozolomide Temozolomide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Desloratadine.
Trimipramine Trimipramine The metabolism of Trimipramine can be increased when combined with Delafloxacin.
Perindopril Perindopril Perindopril may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Escitalopram.
Zonisamide Zonisamide Zonisamide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be increased when combined with Delafloxacin.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Atomoxetine is combined with Delafloxacin.
Atazanavir Atazanavir The metabolism of Delafloxacin can be decreased when combined with Atazanavir.
Almotriptan Almotriptan Almotriptan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Eletriptan Eletriptan The metabolism of Eletriptan can be increased when combined with Delafloxacin.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Delafloxacin.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be increased when combined with Delafloxacin.
Vardenafil Vardenafil The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Delafloxacin.
Alfuzosin Alfuzosin The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Delafloxacin.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Memantine Memantine Memantine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tadalafil Tadalafil Tadalafil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Gemifloxacin.
Progesterone Progesterone Progesterone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Delafloxacin.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Delafloxacin.
Duloxetine Duloxetine Duloxetine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Bosentan Bosentan The metabolism of Bosentan can be increased when combined with Delafloxacin.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Erlotinib Erlotinib The serum concentration of Erlotinib can be decreased when it is combined with Delafloxacin.
Eszopiclone Eszopiclone The serum concentration of Eszopiclone can be decreased when it is combined with Delafloxacin.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The therapeutic efficacy of Insulin aspart can be increased when used in combination with Delafloxacin.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Delafloxacin.
Valganciclovir Valganciclovir Valganciclovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pramlintide Injection Pramlintide Injection The therapeutic efficacy of Pramlintide can be increased when used in combination with Delafloxacin.
Exenatide Injection Exenatide Injection The therapeutic efficacy of Exenatide can be increased when used in combination with Delafloxacin.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Delafloxacin.
Ramelteon Ramelteon Ramelteon may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Fentanyl Fentanyl Fentanyl may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pregabalin Pregabalin The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Delafloxacin.
Deferasirox Deferasirox The metabolism of Delafloxacin can be decreased when combined with Deferasirox.
Tipranavir Tipranavir The metabolism of Delafloxacin can be increased when combined with Tipranavir.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The therapeutic efficacy of Insulin detemir can be increased when used in combination with Delafloxacin.
Ranolazine Ranolazine The metabolism of Ranolazine can be increased when combined with Delafloxacin.
Rasagiline Rasagiline Rasagiline may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Imatinib.
Sitagliptin Sitagliptin The therapeutic efficacy of Sitagliptin can be increased when used in combination with Delafloxacin.
Varenicline Varenicline Delafloxacin may decrease the excretion rate of Varenicline which could result in a higher serum level.
Gefitinib Gefitinib Gefitinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Delafloxacin.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Paliperidone.
Bortezomib Bortezomib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Delafloxacin.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Oxaliplatin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Delafloxacin.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Primaquine.
Pemetrexed Injection Pemetrexed Injection Delafloxacin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Dimenhydrinate.
Retapamulin Retapamulin The metabolism of Retapamulin can be increased when combined with Delafloxacin.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Delafloxacin.
Sorafenib Sorafenib The metabolism of Delafloxacin can be decreased when combined with Sorafenib.
Sunitinib Sunitinib The therapeutic efficacy of Sunitinib can be increased when used in combination with Delafloxacin.
Dronabinol Dronabinol Dronabinol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Delafloxacin.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Delafloxacin.
Pegaptanib Injection Pegaptanib Injection Pegaptanib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dasatinib Dasatinib Dasatinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Azacitidine Injection Azacitidine Injection Azacitidine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Nilotinib Nilotinib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nilotinib.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Bexarotene can be increased when combined with Delafloxacin.
Budesonide Budesonide The risk or severity of tendinopathy can be increased when Budesonide is combined with Delafloxacin.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Doripenem Injection Doripenem Injection Doripenem may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Etravirine Etravirine The metabolism of Etravirine can be increased when combined with Delafloxacin.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Desvenlafaxine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tretinoin Tretinoin The metabolism of Tretinoin can be increased when combined with Delafloxacin.
Flecainide Flecainide The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Flecainide.
Certolizumab Injection Certolizumab Injection Certolizumab pegol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Methylnaltrexone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Midazolam Midazolam Midazolam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Eltrombopag Eltrombopag The metabolism of Delafloxacin can be decreased when combined with Eltrombopag.
Milnacipran Milnacipran The metabolism of Milnacipran can be increased when combined with Delafloxacin.
Plerixafor Injection Plerixafor Injection Plerixafor may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Fesoterodine Fesoterodine Fesoterodine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Degarelix is combined with Delafloxacin.
Betaxolol Betaxolol The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Betaxolol.
Iloperidone Iloperidone The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Iloperidone.
Prasugrel Prasugrel Prasugrel may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Lacosamide can be increased when combined with Delafloxacin.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Pralatrexate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Saxagliptin Saxagliptin The therapeutic efficacy of Saxagliptin can be increased when used in combination with Delafloxacin.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Romidepsin.
Tapentadol Tapentadol The metabolism of Tapentadol can be increased when combined with Delafloxacin.
Topotecan Topotecan Topotecan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pazopanib Pazopanib The metabolism of Delafloxacin can be decreased when combined with Pazopanib.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Asenapine.
Pitavastatin Pitavastatin The metabolism of Pitavastatin can be increased when combined with Delafloxacin.
Liraglutide Injection Liraglutide Injection The therapeutic efficacy of Liraglutide can be increased when used in combination with Delafloxacin.
Dalfampridine Dalfampridine Dalfampridine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Fingolimod Fingolimod The metabolism of Fingolimod can be increased when combined with Delafloxacin.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Eribulin is combined with Delafloxacin.
Cabazitaxel Injection Cabazitaxel Injection Cabazitaxel may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Delafloxacin.
Acetaminophen Injection Acetaminophen Injection Delafloxacin may increase the hepatotoxic activities of Acetaminophen.
Ipilimumab Injection Ipilimumab Injection Ipilimumab may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Delafloxacin.
Roflumilast Roflumilast Roflumilast may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Linagliptin Linagliptin The therapeutic efficacy of Linagliptin can be increased when used in combination with Delafloxacin.
Rilpivirine Rilpivirine Rilpivirine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Telaprevir Telaprevir The metabolism of Delafloxacin can be decreased when combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be increased when combined with Delafloxacin.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Delafloxacin.
Rivaroxaban Rivaroxaban Rivaroxaban may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ruxolitinib Ruxolitinib Ruxolitinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Vandetanib Vandetanib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Vandetanib.
Clobazam Clobazam Clobazam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Vemurafenib.
Vismodegib Vismodegib Vismodegib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Deferiprone Deferiprone Deferiprone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Crizotinib Crizotinib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Crizotinib.
Naloxone Injection Naloxone Injection Naloxone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Enzalutamide Enzalutamide Enzalutamide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Delafloxacin.
Regorafenib Regorafenib The metabolism of Delafloxacin can be decreased when combined with Regorafenib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of tendinopathy can be increased when Corticotropin is combined with Delafloxacin.
Teriflunomide Teriflunomide Teriflunomide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lorcaserin Lorcaserin The therapeutic efficacy of Mecasermin can be increased when used in combination with Delafloxacin.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be increased when combined with Delafloxacin.
Teduglutide Injection Teduglutide Injection Teduglutide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Bedaquiline.
Alogliptin Alogliptin The therapeutic efficacy of Alogliptin can be increased when used in combination with Delafloxacin.
Ponatinib Ponatinib Ponatinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pomalidomide Pomalidomide Pomalidomide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Apixaban Apixaban The metabolism of Apixaban can be increased when combined with Delafloxacin.
Canagliflozin Canagliflozin The therapeutic efficacy of Canagliflozin can be increased when used in combination with Delafloxacin.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib Dabrafenib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ospemifene Ospemifene The metabolism of Ospemifene can be increased when combined with Delafloxacin.
Trametinib Trametinib Trametinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Afatinib Afatinib Afatinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be increased when combined with Delafloxacin.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Vortioxetine Vortioxetine Vortioxetine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Delafloxacin.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Sofosbuvir Sofosbuvir Sofosbuvir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dapagliflozin Dapagliflozin The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Delafloxacin.
Iron Sucrose Injection Iron Sucrose Injection Iron sucrose can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Apremilast Apremilast Apremilast may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ferumoxytol Injection Ferumoxytol Injection Ferumoxytol can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Droxidopa Droxidopa Droxidopa may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ceritinib Ceritinib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ceritinib.
Sodium Ferric Gluconate Injection Sodium Ferric Gluconate Injection Sodium ferric gluconate complex can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Albiglutide Injection Albiglutide Injection The therapeutic efficacy of Albiglutide can be increased when used in combination with Delafloxacin.
Iron Dextran Injection Iron Dextran Injection Iron Dextran can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Carboxymaltose Injection Ferric Carboxymaltose Injection Ferric carboxymaltose can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Empagliflozin Empagliflozin The therapeutic efficacy of Empagliflozin can be increased when used in combination with Delafloxacin.
Dulaglutide Injection Dulaglutide Injection The therapeutic efficacy of Dulaglutide can be increased when used in combination with Delafloxacin.
Edoxaban Edoxaban Edoxaban may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Olaparib Olaparib Olaparib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Methamphetamine Methamphetamine Metamfetamine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tasimelteon Tasimelteon Tasimelteon may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Risperidone Injection Risperidone Injection The risk or severity of QTc prolongation can be increased when Risperidone is combined with Delafloxacin.
Palbociclib Palbociclib Palbociclib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Insulin Human Inhalation Insulin Human Inhalation The therapeutic efficacy of Insulin human can be increased when used in combination with Delafloxacin.
Lenvatinib Lenvatinib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Lenvatinib.
Panobinostat Panobinostat The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Panobinostat.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Haloperidol.
Ivabradine Ivabradine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ivabradine.
Amiloride Amiloride Amiloride may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Macitentan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Rolapitant Rolapitant Rolapitant may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Prednisolone Prednisolone The risk or severity of tendinopathy can be increased when Prednisolone is combined with Delafloxacin.
Daclatasvir Daclatasvir Daclatasvir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ziprasidone.
Penicillin G Procaine Injection Penicillin G Procaine Injection The serum concentration of Delafloxacin can be increased when it is combined with Procaine benzylpenicillin.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The therapeutic efficacy of Insulin degludec can be increased when used in combination with Delafloxacin.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be increased when combined with Delafloxacin.
Alectinib Alectinib Alectinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ixazomib Ixazomib Ixazomib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lesinurad Lesinurad Lesinurad may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The risk or severity of tendinopathy can be increased when Dexamethasone is combined with Delafloxacin.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Venetoclax Venetoclax Venetoclax may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cobicistat Cobicistat Cobicistat may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Rucaparib Rucaparib The metabolism of Delafloxacin can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection The therapeutic efficacy of Lixisenatide can be increased when used in combination with Delafloxacin.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ribociclib.
Brigatinib Brigatinib Brigatinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Doxepin.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Deutetrabenazine.
Valbenazine Valbenazine Valbenazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Deflazacort Deflazacort The risk or severity of tendinopathy can be increased when Deflazacort is combined with Delafloxacin.
Safinamide Safinamide Safinamide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Naldemedine Naldemedine Naldemedine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Enasidenib Enasidenib The metabolism of Delafloxacin can be increased when combined with Enasidenib.
Benznidazole Benznidazole Delafloxacin may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Abemaciclib Abemaciclib Abemaciclib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Letermovir Letermovir Letermovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Semaglutide Injection Semaglutide Injection The therapeutic efficacy of Semaglutide can be increased when used in combination with Delafloxacin.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin The metabolism of Delafloxacin can be decreased when combined with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection Buprenorphine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Apalutamide Apalutamide Apalutamide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Fostamatinib Fostamatinib The metabolism of Delafloxacin can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag Avatrombopag may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Baricitinib Baricitinib Baricitinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Lofexidine.
Plazomicin Injection Plazomicin Injection Delafloxacin may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Eliglustat.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Encorafenib.
Ivosidenib Ivosidenib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ivosidenib.
Cannabidiol Cannabidiol Cannabidiol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dacomitinib Dacomitinib The metabolism of Delafloxacin can be increased when combined with Dacomitinib.
Stiripentol Stiripentol Stiripentol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Gilteritinib Gilteritinib Gilteritinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Glasdegib.
Prucalopride Prucalopride Prucalopride may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Magnesium Citrate Magnesium Citrate Magnesium citrate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Siponimod Siponimod The metabolism of Siponimod can be increased when combined with Delafloxacin.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be increased when combined with Delafloxacin.
Solriamfetol Solriamfetol Delafloxacin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Darolutamide Darolutamide The serum concentration of Delafloxacin can be increased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Triclabendazole.
Entrectinib Entrectinib The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Entrectinib.
Pexidartinib Pexidartinib The metabolism of Delafloxacin can be decreased when combined with Pexidartinib.
Istradefylline Istradefylline Delafloxacin may decrease the excretion rate of Istradefylline which could result in a higher serum level.
Pitolisant Pitolisant Delafloxacin may increase the QTc-prolonging activities of Pitolisant.
Fedratinib Fedratinib Fedratinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lefamulin Lefamulin Lefamulin may increase the QTc-prolonging activities of Delafloxacin.
Phenytoin Injection Phenytoin Injection The metabolism of Phenytoin can be increased when combined with Delafloxacin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be increased when combined with Delafloxacin.
Voxelotor Voxelotor The metabolism of Voxelotor can be increased when combined with Delafloxacin.
Avapritinib Avapritinib The metabolism of Avapritinib can be increased when combined with Delafloxacin.
Lumateperone Lumateperone The serum concentration of Lumateperone can be decreased when it is combined with Delafloxacin.
Lasmiditan Lasmiditan The serum concentration of Delafloxacin can be increased when it is combined with Lasmiditan.
Calcium Acetate Calcium Acetate Calcium acetate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cenobamate Cenobamate The metabolism of Cenobamate can be increased when combined with Delafloxacin.
Selumetinib Selumetinib The metabolism of Selumetinib can be increased when combined with Delafloxacin.
Rimegepant Rimegepant The metabolism of Rimegepant can be increased when combined with Delafloxacin.
Ripretinib Ripretinib Ripretinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Delafloxacin.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Delafloxacin.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Delafloxacin.
Fostemsavir Fostemsavir Fostemsavir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Octreotide Octreotide The risk or severity of QTc prolongation can be increased when Octreotide is combined with Delafloxacin.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Relugolix is combined with Delafloxacin.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Viloxazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Delafloxacin.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Delafloxacin.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Phenobarbital Phenobarbital The metabolism of Delafloxacin can be increased when combined with Phenobarbital.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Primidone Primidone The metabolism of Delafloxacin can be increased when combined with Primidone.
Methsuximide Methsuximide The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Delafloxacin.
Chlorpromazine Chlorpromazine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Chlorpromazine.
Diazepam Diazepam Diazepam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Oxazepam Oxazepam Oxazepam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Flurazepam Flurazepam Flurazepam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Clorazepate Clorazepate Clorazepic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lorazepam Lorazepam Lorazepam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Carmustine Carmustine Carmustine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Amantadine is combined with Delafloxacin.
Codeine Codeine Codeine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Bromocriptine Bromocriptine The therapeutic efficacy of Bromocriptine can be increased when used in combination with Delafloxacin.
Phenelzine Phenelzine Phenelzine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Prochlorperazine.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Thioridazine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dapsone Dapsone The metabolism of Dapsone can be increased when combined with Delafloxacin.
Sulfadiazine Sulfadiazine The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Delafloxacin.
Methadone Methadone The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Methadone.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Delafloxacin.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Delafloxacin.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Orphenadrine Orphenadrine The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Delafloxacin.
Azathioprine Azathioprine Azathioprine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of QTc prolongation can be increased when Amoxapine is combined with Delafloxacin.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Hydrocortisone Hydrocortisone The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Delafloxacin.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Carbamazepine Carbamazepine Carbamazepine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Hydralazine Hydralazine Hydralazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Warfarin Warfarin The metabolism of Warfarin can be increased when combined with Delafloxacin.
Clonazepam Clonazepam The metabolism of Clonazepam can be increased when combined with Delafloxacin.
Loperamide Loperamide The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Loperamide.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Promethazine is combined with Delafloxacin.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin The therapeutic efficacy of Delafloxacin can be decreased when used in combination with Nitrofurantoin.
Digoxin Digoxin Delafloxacin may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Chloroquine.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Quinine.
Ethosuximide Ethosuximide The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ethosuximide.
Triamterene Triamterene Triamterene may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Delafloxacin.
Chlorothiazide Chlorothiazide Chlorothiazide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Chlorthalidone may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be increased when combined with Delafloxacin.
Secobarbital Secobarbital Secobarbital may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Desipramine Desipramine The risk or severity of QTc prolongation can be increased when Desipramine is combined with Delafloxacin.
Amitriptyline Amitriptyline Delafloxacin may increase the QTc-prolonging activities of Amitriptyline.
Imipramine Imipramine The risk or severity of QTc prolongation can be increased when Imipramine is combined with Delafloxacin.
Probenecid Probenecid Probenecid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Quinidine Quinidine Delafloxacin may decrease the excretion rate of Quinidine which could result in a higher serum level.
Procainamide Procainamide Delafloxacin may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Isoniazid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Rifampin Rifampin The metabolism of Delafloxacin can be increased when combined with Rifampicin.
Disopyramide Disopyramide The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Delafloxacin.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Methimazole Methimazole Methimazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Chlorpropamide Chlorpropamide The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Delafloxacin.
Tolbutamide Tolbutamide The therapeutic efficacy of Tolbutamide can be increased when used in combination with Delafloxacin.
Tolazamide Tolazamide The therapeutic efficacy of Tolazamide can be increased when used in combination with Delafloxacin.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be increased when combined with Delafloxacin.
Baclofen Baclofen Baclofen may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Delafloxacin.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Delafloxacin.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Delafloxacin.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Methyclothiazide Methyclothiazide Methyclothiazide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Delafloxacin.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Propranolol.
Nortriptyline Nortriptyline The risk or severity of QTc prolongation can be increased when Nortriptyline is combined with Delafloxacin.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Mercaptopurine Mercaptopurine The metabolism of Mercaptopurine can be decreased when combined with Delafloxacin.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Nadolol Nadolol Nadolol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Delafloxacin.
Flavoxate Flavoxate Flavoxate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Fluorouracil.
Colchicine Colchicine Colchicine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dacarbazine Dacarbazine Dacarbazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Iron Supplements Iron Supplements Iron can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ketoconazole Ketoconazole The metabolism of Delafloxacin can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel Pyrantel may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Delafloxacin.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Delafloxacin.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Alprazolam Alprazolam Delafloxacin may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam Temazepam Temazepam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Triazolam Triazolam Triazolam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Dicyclomine Dicyclomine Dicyclomine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Hyoscyamine Hyoscyamine The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Delafloxacin.
Propantheline Propantheline Propantheline may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Diltiazem Diltiazem The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Diltiazem.
Nifedipine Nifedipine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nifedipine.
Timolol Timolol The risk or severity of QTc prolongation can be increased when Timolol is combined with Delafloxacin.
Verapamil Verapamil Verapamil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pindolol Pindolol Pindolol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection Delafloxacin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Glyburide Glyburide The therapeutic efficacy of Glyburide can be increased when used in combination with Delafloxacin.
Glipizide Glipizide The therapeutic efficacy of Glipizide can be increased when used in combination with Delafloxacin.
Indapamide Indapamide Indapamide may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin The serum concentration of Delafloxacin can be increased when it is combined with Amoxicillin.
Dicloxacillin Dicloxacillin The serum concentration of Delafloxacin can be increased when it is combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The serum concentration of Delafloxacin can be increased when it is combined with Nafcillin.
Oxacillin Injection Oxacillin Injection The serum concentration of Delafloxacin can be increased when it is combined with Oxacillin.
Pentoxifylline Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Delafloxacin.
Pentamidine Injection Pentamidine Injection The therapeutic efficacy of Pentamidine can be increased when used in combination with Delafloxacin.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Auranofin Auranofin Auranofin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Leuprolide.
Gemfibrozil Gemfibrozil The metabolism of Delafloxacin can be decreased when combined with Gemfibrozil.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pimozide Pimozide The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Pimozide.
Flurbiprofen Flurbiprofen The metabolism of Delafloxacin can be decreased when combined with Flurbiprofen.
Amiodarone Amiodarone The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Fluoxetine.
Nimodipine Nimodipine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Nimodipine.
Clozapine Clozapine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Clozapine.
Estazolam Estazolam Estazolam may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Idarubicin Idarubicin The metabolism of Idarubicin can be increased when combined with Delafloxacin.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Ofloxacin.
Didanosine Didanosine Didanosine can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Clarithromycin Clarithromycin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Clarithromycin.
Etodolac Etodolac Etodolac may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Felodipine Felodipine The risk or severity of QTc prolongation can be increased when Felodipine is combined with Delafloxacin.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Quinapril Quinapril Quinapril can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Itraconazole Itraconazole The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Delafloxacin.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Sotalol Sotalol The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Sotalol.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Zolpidem Zolpidem The metabolism of Zolpidem can be increased when combined with Delafloxacin.
Doxazosin Doxazosin The metabolism of Doxazosin can be increased when combined with Delafloxacin.
Isradipine Isradipine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Delafloxacin.
Omeprazole Omeprazole Omeprazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cisapride Cisapride The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be increased when combined with Delafloxacin.
Venlafaxine Venlafaxine The risk or severity of QTc prolongation can be increased when Venlafaxine is combined with Delafloxacin.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Nefazodone Nefazodone Nefazodone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lamotrigine Lamotrigine The metabolism of Delafloxacin can be increased when combined with Lamotrigine.
Losartan Losartan The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Losartan.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Tramadol Tramadol The metabolism of Delafloxacin can be increased when combined with Tramadol.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Moexipril is combined with Delafloxacin.
Lansoprazole Lansoprazole Lansoprazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Delafloxacin.
Nicardipine Nicardipine The risk or severity of QTc prolongation can be increased when Nicardipine is combined with Delafloxacin.
Bupropion Bupropion Bupropion may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Saquinavir Saquinavir The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Saquinavir.
Metformin Metformin The therapeutic efficacy of Metformin can be increased when used in combination with Delafloxacin.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Acarbose Acarbose The therapeutic efficacy of Acarbose can be increased when used in combination with Delafloxacin.
Glimepiride Glimepiride The therapeutic efficacy of Glimepiride can be increased when used in combination with Delafloxacin.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Indinavir Indinavir The metabolism of Delafloxacin can be decreased when combined with Indinavir.
Ritonavir Ritonavir The metabolism of Delafloxacin can be increased when combined with Ritonavir.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Clomipramine Clomipramine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Clomipramine.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be increased when combined with Delafloxacin.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Delafloxacin.
Topiramate Topiramate Topiramate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Zileuton Zileuton The metabolism of Zileuton can be increased when combined with Delafloxacin.
Valsartan Valsartan The metabolism of Valsartan can be increased when combined with Delafloxacin.
Insulin Lispro Injection Insulin Lispro Injection The therapeutic efficacy of Insulin lispro can be increased when used in combination with Delafloxacin.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Donepezil Donepezil The metabolism of Donepezil can be increased when combined with Delafloxacin.
Nelfinavir Nelfinavir The metabolism of Delafloxacin can be increased when combined with Nelfinavir.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Azithromycin.
Carvedilol Carvedilol The metabolism of Carvedilol can be increased when combined with Delafloxacin.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Selegiline Selegiline The metabolism of Selegiline can be increased when combined with Delafloxacin.
Sertraline Sertraline The metabolism of Sertraline can be increased when combined with Delafloxacin.
Propafenone Propafenone The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Propafenone.
Irbesartan Irbesartan The metabolism of Irbesartan can be increased when combined with Delafloxacin.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Quetiapine Quetiapine The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Quetiapine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Delafloxacin.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Citalopram.
Capecitabine Capecitabine The metabolism of Delafloxacin can be increased when combined with Capecitabine.
Efavirenz Efavirenz The metabolism of Delafloxacin can be increased when combined with Efavirenz.
Abacavir Abacavir Abacavir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Sildenafil can be increased when combined with Delafloxacin.
Pioglitazone Pioglitazone The therapeutic efficacy of Pioglitazone can be increased when used in combination with Delafloxacin.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Rosiglitazone Rosiglitazone The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Delafloxacin.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Delafloxacin.
Thalidomide Thalidomide The metabolism of Thalidomide can be increased when combined with Delafloxacin.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Aluminum Hydroxide Aluminum Hydroxide Aluminum hydroxide can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Nateglinide Nateglinide The therapeutic efficacy of Nateglinide can be increased when used in combination with Delafloxacin.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Galantamine is combined with Delafloxacin.
Rabeprazole Rabeprazole Rabeprazole may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Terbinafine Terbinafine The metabolism of Terbinafine can be increased when combined with Delafloxacin.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!